BECTON DICKINSON MEDICAL (SINGAPORE)

Manufacturer adverse-event records for BECTON DICKINSON MEDICAL come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2004–2026 · thin-book · typical Death-code · injury-light

Volume signature

BECTON DICKINSON MEDICAL is a thinner MAUDE footprint

BECTON DICKINSON MEDICAL (SINGAPORE) accounts for 5,400 FDA MAUDE reports (#361 of 434, thin-book tercile). Death-coded event_type share is 0.07% (typical); Injury share 7.8% (injury-light).

What the volume reading shows for BECTON DICKINSON MEDICAL (SINGAPORE)

The standout signal for BECTON DICKINSON MEDICAL (SINGAPORE) is filing volume: 5,400 adverse-event reports in FDA MAUDE (#361 of 434, thin-book). Death-coded event_type share sits at 0.07% (typical).

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Malfunction at 4,973 (92.1% of event_type total). Peak single-year volume reaches 981 reports across 13 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

5,400
Total Reports
4
Event-type Death
422
Injury Reports
20
Device Types

Event Types

Malfunction 4,973 (92.1%)
Injury 422 (7.8%)
Death 4 (0.1%)
Other 1 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

2,666 (49.5%)
Other 2,405 (44.7%)
Required Intervention 295 (5.5%)
R 8 (0.1%)
Death 4 (0.1%)
Hospitalization 3 (0.1%)
L 1 (0.0%)

Yearly Trend

04
2004: 1
15
2015: 21
16
2016: 93
17
2017: 260
18
2018: 489
19
2019: 981
20
2020: 926
21
2021: 981
22
2022: 821
23
2023: 619
24
2024: 116
25
2025: 14
26
2026: 78